Orexo AB (publ) (ORXOY)
OTCMKTS
· Delayed Price · Currency is USD
1.475
-0.375 (-20.27%)
At close: Feb 13, 2025
Orexo AB Employees
Orexo AB had 110 employees as of December 31, 2024. The number of employees decreased by 6 or -5.17% compared to the previous year.
Employees
110
Change (1Y)
-6
Growth (1Y)
-5.17%
Revenue / Employee
$484,637
Profits / Employee
-$166,748
Market Cap
51.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Orexo AB News
- 14 days ago - Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology - PRNewsWire
- 3 months ago - Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis - PRNewsWire
- 4 months ago - Orexo, Abera to develop nasal powder vaccines based on AmorphOX technology - Seeking Alpha
- 4 months ago - Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology - PRNewsWire
- 6 months ago - Orexo initiates new study of OX640 in participants with allergic rhinitis - PRNewsWire
- 6 months ago - Orexo AB reports Q3 results - Seeking Alpha
- 7 months ago - Orexo´s Nomination Committee for the Annual General Meeting 2025 - PRNewsWire
- 8 months ago - Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024 - PRNewsWire